"Huey & Weprin OB/GYN has been providing our patients with the highest quality of care, as well as the latest medical advances to improve health and well-being of all the women. In continuing our commitment in 2006, we added HWC Research Center, which is a private research site supported by an active physician practice. The center is dedicated to research studies involving new medical advances, technologies, devices, and medications. We have experience conducting Phase II, III and IV trials. We recruit both men and women alike. HWC Research Center specializes in a variety of studies, including: General Medicine, Women’s Health, Vaccine Studies, Maternal/Infant Health Studies, Arthritis, Depression, Irritable Bowel Syndrome (IBS), and more!"

During the past decade, HWC Women's Research Center conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 20 clinical trials were completed, i.e. on average, 142.9% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 12 clinical trials were completed. i.e. 240% of trials that started reached the finish line.

Out of the total clinical trials conducted in "HWC Women's Research Center" #1 sponsor was "Bayer" with 5 trials, followed by "Repros Therapeutics Inc." with 4 trials sponsored, "TherapeuticsMD" with 3 trials sponsored, "Astellas Pharma Global Development, Inc." with 2 trials sponsored and "Becton, Dickinson and Company" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "HWC Women's Research Center" #1 collaborator was "Novartis" with 1 trials as a collaborator, "ResearchPoint Global" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "HWC Women's Research Center" are "Hot Flashes" (4 trials), "Endometriosis" (3 trials), "Overactive Bladder" (3 trials), "Menopause" (2 trials) and "Nocturia" (2 trials). Many other conditions were trialed in "HWC Women's Research Center" in a lesser frequency.

Most popular intervention types in "HWC Women's Research Center" are "Drug" (27 trials), "Procedure" (4 trials), "Device" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "placebo" (4 trials), "Colposcopy" (2 trials), "Desmopressin" (2 trials) and "Elinzanetant (BAY3427080)" (2 trials). Other intervention names were less common.

The vast majority of trials in "HWC Women's Research Center" are 26 trials for "Female" genders and 5 trials for "All" genders.

Currently, there are NaN active trials in "HWC Women's Research Center". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in HWC Women's Research Center, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in HWC Women's Research Center, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".